BLOOMINGTON, Ill. (AP) — BLOOMINGTON, Ill. (AP) — HBT Financial Inc. (HBT) on Wednesday reported fourth-quarter earnings of $20.3 million. The Bloomington, Illinois-based bank said it had earnings of 64 cents per share. Earnings, adjusted for non-recurring gains, came to 62 cents per share.
The report studies Head Start programs that are operating under interim management, meaning those whose former managers — usually local agencies or nonprofits — gave up or lost their federal grants due to poor performance.
Man suffers leg injury after colliding with bus on street where stop signs were removed for faster bike access between downtown, IU campus.
Exxon Mobil posted strong fourth quarter profits as the oil and gas company increased production in the Permian basin at home, and in Guyana. The Texas company earned $7.61 billion, or $1.72 per
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...
Wall Street banks are getting ready to sell up to $3 billion of debt holdings in X, the social-media platform controlled by Elon Musk, two sources with knowledge of the matter said Friday.
Bloomington's Community Development department has launched an interactive map detailing local development projects.
Banks are getting ready to sell billions of dollars in debt borrowed by Elon Musk’s X, bringing Wall Street a step closer to exiting the nerve-racking deal that financed the social-media company ...
General Motors swung to a loss in the fourth quarter on huge charges related to China, but still topped profit and revenue expectations on Wall Street. Last month GM cautioned that the poor
(OMF) on Friday reported fourth-quarter earnings of $126 million. On a per-share basis, the Evansville, Indiana-based company said it had profit of $1.05. Earnings, adjusted for non-recurring costs, came to $1.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.